Search

Melvyn I Marquis

Examiner (ID: 16161)

Most Active Art Unit
1501
Art Unit(s)
1402, 1505, 1503, 1501, 1712, 2200, 1754, 1401
Total Applications
2620
Issued Applications
2300
Pending Applications
26
Abandoned Applications
294

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8221209 [patent_doc_number] => 20120135402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'GENE SEQUENCE VARIANCES IN GENES RELATED TO FOLATE METABOLISM HAVING UTILITY IN DETERMINING THE TREATMENT OF DISEASE' [patent_app_type] => utility [patent_app_number] => 13/112371 [patent_app_country] => US [patent_app_date] => 2011-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 64762 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13112371 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/112371
GENE SEQUENCE VARIANCES IN GENES RELATED TO FOLATE METABOLISM HAVING UTILITY IN DETERMINING THE TREATMENT OF DISEASE May 19, 2011 Abandoned
Array ( [id] => 8884689 [patent_doc_number] => 20130157873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-20 [patent_title] => 'METHODS OF ASSESSING A RISK OF DEVELOPING NECROTIZING MENINGOENCEPHALITIS' [patent_app_type] => utility [patent_app_number] => 13/698907 [patent_app_country] => US [patent_app_date] => 2011-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8821 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13698907 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/698907
METHODS OF ASSESSING A RISK OF DEVELOPING NECROTIZING MENINGOENCEPHALITIS May 18, 2011 Abandoned
Array ( [id] => 8684360 [patent_doc_number] => 20130052644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => 'Predictive Markers Useful in the Treatment of Fragile X Syndrome (FXS)' [patent_app_type] => utility [patent_app_number] => 13/695214 [patent_app_country] => US [patent_app_date] => 2011-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18637 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13695214 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/695214
Predictive Markers Useful in the Treatment of Fragile X Syndrome (FXS) Apr 27, 2011 Abandoned
Array ( [id] => 9823327 [patent_doc_number] => 08932810 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-13 [patent_title] => 'Identification of mutation and method for detecting lavender foal syndrome in the horse' [patent_app_type] => utility [patent_app_number] => 13/093173 [patent_app_country] => US [patent_app_date] => 2011-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8254 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13093173 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/093173
Identification of mutation and method for detecting lavender foal syndrome in the horse Apr 24, 2011 Issued
Array ( [id] => 8140605 [patent_doc_number] => 20120094854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'METHODS AND COMPOSITIONS FOR THE TREATMENT OF PSYCHOTIC DISORDERS THROUGH THE IDENTIFICATION OF THE OLANZAPINE POOR RESPONSE PREDICTOR GENE SIGNATURE' [patent_app_type] => utility [patent_app_number] => 13/093543 [patent_app_country] => US [patent_app_date] => 2011-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 24407 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20120094854.pdf [firstpage_image] =>[orig_patent_app_number] => 13093543 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/093543
METHODS AND COMPOSITIONS FOR THE TREATMENT OF PSYCHOTIC DISORDERS THROUGH THE IDENTIFICATION OF THE OLANZAPINE POOR RESPONSE PREDICTOR GENE SIGNATURE Apr 24, 2011 Abandoned
Array ( [id] => 8815099 [patent_doc_number] => 20130116144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-09 [patent_title] => 'METHYLATION MARKER FOR DIAGNOSIS OF CERVICAL CANCER' [patent_app_type] => utility [patent_app_number] => 13/642407 [patent_app_country] => US [patent_app_date] => 2011-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11681 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13642407 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/642407
METHYLATION MARKER FOR DIAGNOSIS OF CERVICAL CANCER Apr 21, 2011 Abandoned
Array ( [id] => 6046657 [patent_doc_number] => 20110206667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'POLYMORPHISM IN THE APO(A) GENE PREDICT RESPONSIVENESS TO ACETYLSALICYLIC ACID TREATMENT' [patent_app_type] => utility [patent_app_number] => 13/090116 [patent_app_country] => US [patent_app_date] => 2011-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17202 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20110206667.pdf [firstpage_image] =>[orig_patent_app_number] => 13090116 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/090116
POLYMORPHISM IN THE APO(A) GENE PREDICT RESPONSIVENESS TO ACETYLSALICYLIC ACID TREATMENT Apr 18, 2011 Abandoned
Array ( [id] => 10122771 [patent_doc_number] => 09157123 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-13 [patent_title] => 'Genetic amplification of IQGAP1 in cancer' [patent_app_type] => utility [patent_app_number] => 13/641994 [patent_app_country] => US [patent_app_date] => 2011-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7942 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 241 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13641994 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/641994
Genetic amplification of IQGAP1 in cancer Apr 14, 2011 Issued
Array ( [id] => 7574079 [patent_doc_number] => 20110269735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'GENETIC POLYMORPHISMS ASSOCIATED WITH STATIN RESPONSE AND CARDIOVASCULAR DISEASES, METHODS OF DETECTION AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/085955 [patent_app_country] => US [patent_app_date] => 2011-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61758 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269735.pdf [firstpage_image] =>[orig_patent_app_number] => 13085955 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/085955
GENETIC POLYMORPHISMS ASSOCIATED WITH STATIN RESPONSE AND CARDIOVASCULAR DISEASES, METHODS OF DETECTION AND USES THEREOF Apr 12, 2011 Abandoned
Array ( [id] => 8139681 [patent_doc_number] => 20120094389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'Single Nucleotide Polymorphisms That Predict HCV Treatment Outcomes' [patent_app_type] => utility [patent_app_number] => 13/084187 [patent_app_country] => US [patent_app_date] => 2011-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9183 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20120094389.pdf [firstpage_image] =>[orig_patent_app_number] => 13084187 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/084187
Single Nucleotide Polymorphisms That Predict HCV Treatment Outcomes Apr 10, 2011 Abandoned
Array ( [id] => 7487916 [patent_doc_number] => 20110251252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'BIOMARKERS FOR MDM2 INHIBITORS FOR USE IN TREATING DISEASE' [patent_app_type] => utility [patent_app_number] => 13/082163 [patent_app_country] => US [patent_app_date] => 2011-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21699 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20110251252.pdf [firstpage_image] =>[orig_patent_app_number] => 13082163 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/082163
BIOMARKERS FOR MDM2 INHIBITORS FOR USE IN TREATING DISEASE Apr 6, 2011 Abandoned
Array ( [id] => 5958948 [patent_doc_number] => 20110183335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'METHODS AND COMPOSITIONS FOR PERIOPERATIVE GENOMIC PROFILING' [patent_app_type] => utility [patent_app_number] => 13/078587 [patent_app_country] => US [patent_app_date] => 2011-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19991 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20110183335.pdf [firstpage_image] =>[orig_patent_app_number] => 13078587 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/078587
METHODS AND COMPOSITIONS FOR PERIOPERATIVE GENOMIC PROFILING Mar 31, 2011 Abandoned
Array ( [id] => 7696711 [patent_doc_number] => 20110229879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'METHODS AND COMPOSITIONS FOR NUCLEAR STAINING' [patent_app_type] => utility [patent_app_number] => 13/052791 [patent_app_country] => US [patent_app_date] => 2011-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3937 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229879.pdf [firstpage_image] =>[orig_patent_app_number] => 13052791 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/052791
METHODS AND COMPOSITIONS FOR NUCLEAR STAINING Mar 20, 2011 Abandoned
Array ( [id] => 7500366 [patent_doc_number] => 20110262915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'METHOD FOR PREDICTING THE ATHLETIC PERFORMANCE POTENTIAL OF A SUBJECT' [patent_app_type] => utility [patent_app_number] => 13/046432 [patent_app_country] => US [patent_app_date] => 2011-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16523 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262915.pdf [firstpage_image] =>[orig_patent_app_number] => 13046432 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/046432
METHOD FOR PREDICTING THE ATHLETIC PERFORMANCE POTENTIAL OF A SUBJECT Mar 10, 2011 Abandoned
Array ( [id] => 6014890 [patent_doc_number] => 20110223180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'METHODS AND COMPOSITIONS RELATED TO A MULTI-METHYLATION ASSAY TO PREDICT PATIENT OUTCOME' [patent_app_type] => utility [patent_app_number] => 13/044934 [patent_app_country] => US [patent_app_date] => 2011-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13906 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20110223180.pdf [firstpage_image] =>[orig_patent_app_number] => 13044934 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/044934
METHODS AND COMPOSITIONS RELATED TO A MULTI-METHYLATION ASSAY TO PREDICT PATIENT OUTCOME Mar 9, 2011 Abandoned
Array ( [id] => 6161213 [patent_doc_number] => 20110159494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'Analyzing the FMR1 Gene' [patent_app_type] => utility [patent_app_number] => 13/043199 [patent_app_country] => US [patent_app_date] => 2011-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 34939 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20110159494.pdf [firstpage_image] =>[orig_patent_app_number] => 13043199 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/043199
Analyzing the FMR1 Gene Mar 7, 2011 Abandoned
Array ( [id] => 7663265 [patent_doc_number] => 20110312534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'METHOD FOR PREDICTION OF HUMAN IRIS COLOR' [patent_app_type] => utility [patent_app_number] => 13/041109 [patent_app_country] => US [patent_app_date] => 2011-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 27647 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20110312534.pdf [firstpage_image] =>[orig_patent_app_number] => 13041109 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/041109
METHOD FOR PREDICTION OF HUMAN IRIS COLOR Mar 3, 2011 Abandoned
Array ( [id] => 7567367 [patent_doc_number] => 20110287430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'NON-THIOPURINE METHYLTRANSFERASE RELATED EFFECTS IN 6-MERCAPTOPURINE THERAPY' [patent_app_type] => utility [patent_app_number] => 13/039505 [patent_app_country] => US [patent_app_date] => 2011-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8675 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20110287430.pdf [firstpage_image] =>[orig_patent_app_number] => 13039505 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/039505
Non-thiopurine methyltransferase related effects in 6-mercaptopurine therapy Mar 2, 2011 Issued
Array ( [id] => 9112815 [patent_doc_number] => 08568984 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-29 [patent_title] => 'Methods of diagnosing non-urinary tract diseases by detecting aberrant methylation' [patent_app_type] => utility [patent_app_number] => 13/030888 [patent_app_country] => US [patent_app_date] => 2011-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 16 [patent_no_of_words] => 15135 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13030888 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/030888
Methods of diagnosing non-urinary tract diseases by detecting aberrant methylation Feb 17, 2011 Issued
Array ( [id] => 8617662 [patent_doc_number] => 20130022975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-24 [patent_title] => 'METHOD FOR DETECTING ARTERIOSCLEROTIC DISEASES ON THE BASIS OF SINGLE NUCLEOTIDE POLYMORPHISM AT HUMAN CHROMOSOME 5P15.3' [patent_app_type] => utility [patent_app_number] => 13/579463 [patent_app_country] => US [patent_app_date] => 2011-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5231 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13579463 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/579463
METHOD FOR DETECTING ARTERIOSCLEROTIC DISEASES ON THE BASIS OF SINGLE NUCLEOTIDE POLYMORPHISM AT HUMAN CHROMOSOME 5P15.3 Feb 17, 2011 Abandoned
Menu